Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Northwest Biotherapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$48.34M. For fiscal 2025 it was -$44.76M. The highest annual figure on record is -$6.38M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$44.76M | – |
| FY2024 | Dec 31, 2024 | -$57.02M | – |
| FY2023 | Dec 31, 2023 | -$53.64M | – |
| FY2022 | Dec 31, 2022 | -$52.78M | – |
| FY2021 | Dec 31, 2021 | -$38.30M | – |
| FY2020 | Dec 31, 2020 | -$32.09M | – |
| FY2019 | Dec 31, 2019 | -$31.86M | – |
| FY2018 | Dec 31, 2018 | -$34.59M | – |
| FY2017 | Dec 31, 2017 | -$36.50M | – |
| FY2016 | Dec 31, 2016 | -$55.65M | – |
| FY2015 | Dec 31, 2015 | -$79.71M | – |
| FY2014 | Dec 31, 2014 | -$54.58M | – |
| FY2013 | Dec 31, 2013 | -$37.80M | – |
| FY2012 | Dec 31, 2012 | -$22.75M | – |
| FY2011 | Dec 31, 2011 | -$14.71M | – |
| FY2010 | Dec 31, 2010 | -$6.38M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.17M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.51M | – |
| Q4 FY2025 | Dec 31, 2025 | -$14.76M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.89M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.69M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.42M | – |
| Q4 FY2024 | Dec 31, 2024 | -$20.18M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.41M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.96M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.92M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.52M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.24M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.85M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.12M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.84M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.97M | – |
| Q4 FY2021 | Dec 31, 2021 | -$11.25M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.01M | – |
| Q4 FY2020 | Dec 31, 2020 | -$10.20M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.02M | – |
| Q2 FY2020 | Jun 30, 2020 | -$6.33M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.54M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.98M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.45M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.68M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.75M | – |
| Q4 FY2018 | Dec 31, 2018 | -$14.18M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.05M | – |
| Q2 FY2018 | Jun 30, 2018 | -$11.57M | -218.0% |
| Q1 FY2018 | Mar 31, 2018 | -$4.79M | – |
| Q4 FY2017 | Dec 31, 2017 | -$14.79M | – |
| Q4 FY2016 | Dec 31, 2016 | -$14.10M | – |
| Q3 FY2016 | Sep 30, 2016 | $9.80M | – |
| Q2 FY2016 | Jun 30, 2016 | -$14.21M | – |
| Q1 FY2016 | Mar 31, 2016 | -$17.60M | – |
| Q4 FY2015 | Dec 31, 2015 | -$23.23M | – |
See a number that looks wrong?